SCHEMBL5013453

SCHEMBL5013453

O=C=NCC1CCC1CN=C=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL302555 0.89 ALDH1A1 (0.39) ALDH1A1
SCHEMBL22899091 0.89 ALDH1A1 (0.33) ALDH1A1
SCHEMBL30850070 0.84 INPP5A (0.31)
SCHEMBL22899011 0.83 ALDH1A1 (0.34) ALDH1A1
SCHEMBL26405376 0.82
SCHEMBL22899096 0.82
SCHEMBL2330759 0.79
SCHEMBL44332 0.77 ALDH1A1 (0.31) ALDH1A1
SCHEMBL19732912 0.77 ALDH1A1 (0.31) ALDH1A1
SCHEMBL1081546 0.77 ALDH1A1 (0.31) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110352223-B Coating composition with covalently bound UV absorber 巴斯夫欧洲公司 2022-08-02 CN claimed
US-11254837-B2 Coating compositions having covalently bound ultraviolet absorbers BASF SE 2022-02-22 US claimed
US-20210206996-A1 COATING COMPOSITIONS HAVING COVALENTLY BOUND ULTRAVIOLET ABSORBERS BASF SE (DE) 2021-07-08 US claimed
EP-3691901-A1 UV CURABLE COMPOSITIONS WITH CONTROLLED MECHANICAL AND CHEMICAL PROPERTIES, METHODS, AND ARTICLES THEREFROM BASF SE (DE) 2020-08-12 EP claimed
US-20200247932-A1 UV CURABLE COMPOSITIONS WITH CONTROLLED MECHANICAL AND CHEMICAL PROPERTIES, METHODS, AND ARTICLES THEREFROM BASF CORPORATION 2020-08-06 US claimed
EP-3615622-A1 COATING COMPOSITIONS HAVING COVALENTLY BOUND ULTRAVIOLET ABSORBERS BASF SE (DE) 2020-03-04 EP claimed
WO-2019070587-A1 UV CURABLE COMPOSITIONS WITH CONTROLLED MECHANICAL AND CHEMICAL PROPERTIES, METHODS, AND ARTICLES THEREFROM BASF SE (DE) 2019-04-11 WO claimed
WO-2018199927-A1 COATING COMPOSITIONS HAVING COVALENTLY BOUND ULTRAVIOLET ABSORBERS BASF SE (DE) 2018-11-01 WO claimed
US-20150259280-A1 Ethylenically Unsaturated Oligomers BASF SE (DE) 2015-09-17 US claimed
US-20060167208-A1 Urethane acrylate gel coat resin and method of making VALSPAR SOURCING, INC. (US) 2006-07-27 US claimed
WO-2004014978-A1 URETHANE ACRYLATE GEL COAT RESIN AND METHOD OF MAKING VALSPAR SOURCING, INC. (US) 2004-02-19 WO claimed
US-5103045-A Reacting acid with diisocyanate RHONE-POULENC CHIMIE (FR) 1992-04-07 US claimed
EP-0259233-B1 PROCESS FOR THE PREPARATION OF POLYISOCYANATES WITH A BIURET STRUCTURE RHONE-POULENC CHIMIE (FR) 1991-09-25 EP claimed
EP-0263044-B1 PROCESS FOR THE ISOLATION AND PURIFICATION OF POLYISOCYANATES CONTAINING BIURET GROUPS RHONE-POULENC CHIMIE (FR) 1991-07-10 EP claimed
US-4983762-A From aliphatic, alicyclic or arylaliphatic diisocyanate, water, liquid form, carbon dioxide RHONE-POULENC CHIMIE DE BASE (FR) 1991-01-08 US claimed
US-4871460-A Isolation/purification of isocyanate condensates by extraction with liquid or supercritical gas RHONE-POULENC CHIMIE (FR) 1989-10-03 US claimed
US-4864025-A VERY LOW CONCENTRATIONS OF DIMER AND/OR RESIDUAL MONOMER; INTERMEDIATES FOR POLYURETHANE PAINTS AND VARNISHES RHONE-POULENC CHIMIE (FR) 1989-09-05 US claimed
EP-0227562-B1 PROCESS FOR ENCAPSULATION BY INTERFACIAL POLYADDITION RHONE-POULENC CHIMIE (FR) 1989-06-07 EP claimed
US-4738898-A Microencapsulation by interfacial polyaddition RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1988-04-19 US claimed
US-4412073-A Isocyanurate preparation by catalytic, aminosilyl initiated cyclotrimerization of isocyanates RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-10-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259280-A1 Ethylenically Unsaturated Oligomers VCL, INCENP, PCMT1 ALDH1A1 647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.